Table 5.
Correlation between Tyr/Thr and sST2, hsCRP, or NT‐proBNP in HF subjects
| n | Unadjusted OR | P value | Adjusted OR | P value | |
|---|---|---|---|---|---|
| sST2 | |||||
| Tyr/Thr | 66 | 1.946 (1.013–3.737) | 0.046 | 2.755 (1.105–6.873) | 0.030 |
| hsCRP | |||||
| Tyr/Thr | 270 | 1.421 (1.044–1.934) | 0.026 | 1.728 (1.212–2.464) | 0.003 |
| Log NT‐proBNP | |||||
| Tyr/Thr | 318 | 1.319 (0.994–1.750) | 0.055 | 1.737 (1.187–2.544) | 0.005 |
Adjusted for sex, age, low systolic BP, BMI, heart rate, smoking, drinking, DM, hyperlipidaemia, stroke, AF, coronary disease, ALT, and low eGFR.
HF, heart failure; hsCRP, high‐sensitivity C‐reactive protein; NT‐proBNP, N‐terminal brain natriuretic peptide; OR, odds ratio; sST2, the soluble form of suppression of tumourigenicity 2 protein; Tyr/Thr, tyrosine/threonine.